# Cytotron® Delivered Rotational Field Quantum Nuclear Magnetic Resonance Therapy for Multiple Sclerosis

> **NCT01220830** · PHASE2 · UNKNOWN · sponsor: **The Centre for Advanced Research & Development, India** · enrollment: 40 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DEVICE:** Cytotron

## Key facts

- **NCT ID:** NCT01220830
- **Lead sponsor:** The Centre for Advanced Research & Development, India
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-09
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2011-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01220830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01220830, "Cytotron® Delivered Rotational Field Quantum Nuclear Magnetic Resonance Therapy for Multiple Sclerosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01220830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*